EichorEICHOR
Location: Pico Rivera Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Pico Rivera

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Phase 2 · CNRI Los Angeles LLC · Novartis Pharmaceuticals · NCT07467993
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Maj
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06966401
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT07114874
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06963034
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive
Phase 3 · Neurocrine Clinical Site · Neurocrine Biosciences · NCT06786624
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Phase 3 · Integrity Medical Discovery · Prokidney · NCT05099770
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Phase 3 · CNRI-Los Angeles, LLC · Intra-Cellular Therapies, Inc. · NCT05850689
Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06961968
Look up another city
Look up another condition